London, 27th November 2023
Celix Pharma reports profitability in its first year of commercial operations
Celix Pharma, a start-up generic pharmaceutical company based in London, is pleased to announce its achievement of profitability in its inaugural year of commercial operation: FY22-23. This milestone underscores the company's unwavering dedication to innovation, quality and agility, as evidenced by its filing of 17 products, securing 12 approvals and 6 product launches by the end of FY22-23.
Celix Pharma currently has 9 products on the market. Looking forward, the company has ambitious plans for several new product launches in FY23-24 (and beyond) and is actively seeking talented and passionate individuals to join its team and contribute to its exciting journey.
Expressing his delight, Subir Kohli, CEO of Celix Pharma, stated, "We are thrilled to have achieved profitability in our first year of commercial operation. This significant milestone underscores our commitment to developing and launching high-quality generic drugs that cater to the needs of our customers and ultimately, the patients."
Shantreddy, COO of Celix Pharma, added, "Celix Pharma's rapid launch of six products within a short timeframe is a testament to our execution orientation and adaptability. We eagerly anticipate the company's future prospects and remain committed to fostering innovation and maintaining superior quality."
VS Vasudevan, an early investor and board member of Celix Pharma, commented, "Celix Pharma's achievement of profitability in its first year of commercial operation reflects its robust business model and operational efficiency. We are excited about Celix Pharma's future prospects and look forward to supporting its continued growth and success."
About Celix Pharma Ltd
Celix Pharma is a dynamic generic pharmaceutical company founded in 2020 and headquartered in London. The company is committed to bringing high quality, affordable, generic medicines into the UK for the health and well-being of patients, in line with its stated purpose “...for better health”. Celix Pharma focuses on bridging gaps in the market created through complexities in product development and/or manufacturing, supply disruptions and opportunities created by future patent cliffs. Celix Pharma is building a portfolio across primary and secondary care, with a range of generics, branded generics, and hospital specialty products.
For media inquiries, please contact:
For career opportunities, please visit www.celixpharma.com/careers or contact: